Asymmetry Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
MWNA
Asymmetry Capital Management's DGX Position: Q3 2018 in Review
Asymmetry Capital Management sold out of Quest Diagnostics (DGX) in Q3 2018, closing a stake of 24,575 shares — an estimated $2.7M sold.
Asymmetry Capital Management first reported a position in DGX in Q3 2015 and held it in 12 quarters. The position peaked at $6.65M in Q4 2015. 673 funds tracked by Wall St. Rank hold DGX as of Q3 2018.
- Asymmetry Capital Management reported no remaining Quest Diagnostics position as of Q3 2018 after selling out during the quarter.
- Asymmetry Capital Management sold 24,575 Quest Diagnostics shares in Q3 2018, an estimated $2.7M.
- Asymmetry Capital Management first reported a position in Quest Diagnostics in Q3 2015 and held it in 12 quarters.
- Asymmetry Capital Management's Quest Diagnostics position peaked at $6.65M in Q4 2015.
- 673 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.
Based on Asymmetry Capital Management's 13F filing for Q3 2018, filed 8 Nov 2018.